A detailed history of Accordant Advisory Group Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Accordant Advisory Group Inc holds 10,896 shares of JNJ stock, worth $1.69 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
10,896
Previous 20,678 47.31%
Holding current value
$1.69 Million
Previous $3.02 Billion 41.57%
% of portfolio
1.41%
Previous 2.86%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$145.48 - $167.38 $1.42 Million - $1.64 Million
-9,782 Reduced 47.31%
10,896 $1.77 Billion
Q2 2024

Jul 18, 2024

BUY
$144.38 - $157.78 $2.17 Million - $2.37 Million
15,050 Added 267.41%
20,678 $3.02 Billion
Q1 2024

Apr 22, 2024

BUY
$155.22 - $162.74 $873,578 - $915,900
5,628 New
5,628 $890 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Accordant Advisory Group Inc Portfolio

Follow Accordant Advisory Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accordant Advisory Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Accordant Advisory Group Inc with notifications on news.